The use of liposomal bupivacaine in fracture surgery: a review
- PMID: 37005638
- PMCID: PMC10068181
- DOI: 10.1186/s13018-023-03583-1
The use of liposomal bupivacaine in fracture surgery: a review
Abstract
Historically, opioids have played a major role in the treatment of postoperative pain in orthopedic surgery. A multitude of adverse events have been associated with opioid use and alternative approaches to pain relief are being investigated, with particular focus on multimodal pain management regimens. Liposomal bupivacaine (EXPAREL) is a component of some multimodal regimens. This formulation of bupivacaine encapsulates the local anesthetic into a multivesicular liposome to theoretically deliver a consistent amount of drug for up to 72 hours. Although the use of liposomal bupivacaine has been studied in many areas of orthopedics, there is little evidence evaluating its use in patients with fractures. This systematic review of the available data identified a total of eight studies evaluating the use of liposomal bupivacaine in patients with fractures. Overall, these studies demonstrated mixed results. Three studies found no difference in postoperative pain scores on postoperative days 1-4, while two studies found significantly lower pain scores on the day of surgery. Three of the studies evaluated the quantity of narcotic consumption postoperatively and failed to find a significant difference between control groups and groups treated with liposomal bupivacaine. Further, significant variability in comparison groups and study designs made interpretation of the available data difficult. Given this lack of clear evidence, there is a need for prospective, randomized clinical trials focused on fully evaluating the use of liposomal bupivacaine in fracture patients. At present, clinicians should maintain a healthy skepticism and rely on their own interpretation of the available data before widely implementing the use of liposomal bupivacaine.
Keywords: EXPAREL; Fracture; Liposomal bupivacaine; Multimodal; Orthopedic surgery; Postoperative pain.
© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Conflict of interest statement
No authors hold any competing interests in a personal or financial nature with regards to this manuscript.
Figures
Similar articles
-
The Efficacy of Liposomal Bupivacaine for Opioid and Pain Reduction: A Systematic Review of Randomized Clinical Trials.J Surg Res. 2021 Aug;264:510-533. doi: 10.1016/j.jss.2021.02.024. Epub 2021 Apr 13. J Surg Res. 2021. PMID: 33862580
-
No Difference in Early Analgesia Between Liposomal Bupivacaine Injection and Intrathecal Morphine After TKA.Clin Orthop Relat Res. 2017 Jan;475(1):94-105. doi: 10.1007/s11999-016-4931-z. Clin Orthop Relat Res. 2017. PMID: 27339124 Free PMC article. Clinical Trial.
-
Evolving Role of Local Anesthetics in Managing Postsurgical Analgesia.Clin Ther. 2015 Jun 1;37(6):1354-71. doi: 10.1016/j.clinthera.2015.03.017. Epub 2015 Apr 10. Clin Ther. 2015. PMID: 25866297 Review.
-
Evaluating the Efficacy of Liposomal Bupivacaine in Postoperative Pain Management for Rhinoplasty: A Retrospective Study.Aesthetic Plast Surg. 2024 May;48(9):1722-1727. doi: 10.1007/s00266-023-03656-w. Epub 2023 Sep 29. Aesthetic Plast Surg. 2024. PMID: 37775576
-
The efficiency and safety of local liposomal bupivacaine infiltration for pain control in total hip arthroplasty: A systematic review and meta-analysis.Medicine (Baltimore). 2017 Dec;96(49):e8433. doi: 10.1097/MD.0000000000008433. Medicine (Baltimore). 2017. PMID: 29245214 Free PMC article. Review.
Cited by
-
Advances in the use of local anesthetic extended-release systems in pain management.Drug Deliv. 2024 Dec;31(1):2296349. doi: 10.1080/10717544.2023.2296349. Epub 2023 Dec 21. Drug Deliv. 2024. PMID: 38130151 Free PMC article. Review.
References
-
- Number of all-listed procedures for discharges from short-stay hospitals, by procedure category and age: United States, 2010. Centers for Disease Control and Prevention. Published online 2010:2.
-
- Brown CA, Starr AZ, Nunley JA. Analysis of Past Secular Trends of Hip Fractures and Predicted Number in the Future 2010–2050 | Ovid. Accessed Sept 9, 2019. https://oce-ovid-com.libproxy.lib.unc.edu/article/00005131-201202000-000.... - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources